Total Payments
$499.42
2023 Payments
$18.47
Companies
17
Transactions
35
Medicare Patients
777
Medicare Billing
$86,597
Payment Breakdown by Category
Food & Beverage$499.42 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $499.42 | 35 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan Inc. | $64.65 | 4 | $0 (2019) |
| Supernus Pharmaceuticals, Inc. | $58.84 | 4 | $0 (2020) |
| Sunovion Pharmaceuticals Inc. | $55.92 | 5 | $0 (2019) |
| Novo Nordisk Inc | $52.84 | 4 | $0 (2019) |
| Astellas Pharma US Inc | $51.65 | 3 | $0 (2019) |
| GlaxoSmithKline, LLC. | $38.52 | 3 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $23.62 | 2 | $0 (2020) |
| Phadia US Inc. | $22.28 | 1 | $0 (2018) |
| Upsher-Smith Laboratories LLC | $18.79 | 1 | $0 (2019) |
| C. R. Bard, Inc. & Subsidiaries | $18.47 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $18.47 | 1 | C. R. Bard, Inc. & Subsidiaries ($18.47) |
| 2020 | $25.24 | 2 | Supernus Pharmaceuticals, Inc. ($13.09) |
| 2019 | $326.42 | 23 | Allergan Inc. ($46.42) |
| 2018 | $83.96 | 5 | Phadia US Inc. ($22.28) |
| 2017 | $45.33 | 4 | Allergan Inc. ($18.23) |
All Payment Transactions
35 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/21/2023 | C. R. Bard, Inc. & Subsidiaries | Arctic Sun 5000 (Device) | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: Catheter Care and Medication Delivery | ||||||
| 01/21/2020 | Supernus Pharmaceuticals, Inc. | TROKENDI XR (Drug) | Food and Beverage | Cash or cash equivalent | $13.09 | General |
| Category: AED | ||||||
| 01/07/2020 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $12.15 | General |
| Category: Endocrinology | ||||||
| 10/31/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: Diabetes | ||||||
| 09/27/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.04 | General |
| Category: NEUROSCIENCE | ||||||
| 09/11/2019 | Supernus Pharmaceuticals, Inc. | TROKENDI XR (Drug) | Food and Beverage | Cash or cash equivalent | $11.10 | General |
| Category: AED | ||||||
| 08/23/2019 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $11.40 | General |
| Category: RESPIRATORY | ||||||
| 08/15/2019 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, JANUMET XR | Food and Beverage | In-kind items and services | $15.93 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/14/2019 | Supernus Pharmaceuticals, Inc. | TROKENDI XR (Drug) | Food and Beverage | Cash or cash equivalent | $18.75 | General |
| Category: AED | ||||||
| 08/08/2019 | Sunovion Pharmaceuticals Inc. | LONHALA MAGNAIR (Drug) | Food and Beverage | In-kind items and services | $8.97 | General |
| Category: RESPIRATORY | ||||||
| 08/06/2019 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $14.21 | General |
| 08/01/2019 | Allergan Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/27/2019 | Allergan Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/23/2019 | Upsher-Smith Laboratories LLC | QUDEXY XR Topiramate Extended Release Capsules (Drug) | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: Neurology | ||||||
| 05/15/2019 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $12.17 | General |
| Category: RESPIRATORY | ||||||
| 05/07/2019 | PFIZER INC. | LYRICA (Drug), EUCRISA, COLOGUARD | Food and Beverage | In-kind items and services | $11.87 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 04/23/2019 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: UROLOGY | ||||||
| 04/16/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: Hypertriglyceridemia | ||||||
| 04/15/2019 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: Diabetes | ||||||
| 04/02/2019 | Teva Pharmaceuticals USA, Inc. | AJOVY (Drug) | Food and Beverage | In-kind items and services | $11.16 | General |
| Category: Central Nervous System | ||||||
| 03/26/2019 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Drug) | Food and Beverage | In-kind items and services | $11.47 | General |
| Category: DIABETES | ||||||
| 03/18/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT, SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $11.84 | General |
| Category: RESPIRATORY | ||||||
| 03/06/2019 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $12.43 | General |
| 02/12/2019 | Sunovion Pharmaceuticals Inc. | LONHALA MAGNAIR (Drug) | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: RESPIRATORY | ||||||
| 01/22/2019 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $21.67 | General |
| Category: UROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 59 | 68 | $17,000 | $3,285 |
| 2022 | 6 | 215 | 290 | $73,321 | $24,285 |
| 2021 | 7 | 259 | 374 | $90,722 | $35,928 |
| 2020 | 7 | 244 | 330 | $63,258 | $23,099 |
Total Patients
777
Total Services
1,062
Medicare Billing
$86,597
Procedure Codes
21
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 59 | 68 | $17,000 | $3,285 | 19.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 125 | 200 | $50,000 | $15,117 | 30.2% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 19 | 19 | $9,462 | $3,240 | 34.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 19 | 19 | $3,838 | $2,370 | 61.7% |
| 45384 | Removal of polyps or growths of large bowel using a flexible endoscope with electrical cautery | Facility | 2022 | 13 | 13 | $8,099 | $1,933 | 23.9% |
| 90682 | Influenza vaccine, quadrivalent derived from recombinant dna | Office | 2022 | 19 | 19 | $1,102 | $1,080 | 98.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 20 | 20 | $820.00 | $545.40 | 66.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 74 | 163 | $33,064 | $13,729 | 41.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 52 | 52 | $10,504 | $6,604 | 62.9% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2021 | 32 | 32 | $15,936 | $5,686 | 35.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 65 | 91 | $11,574 | $5,222 | 45.1% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 12 | 12 | $8,460 | $2,179 | 25.8% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 12 | 12 | $7,116 | $1,360 | 19.1% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 12 | 12 | $4,068 | $1,149 | 28.2% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2020 | 40 | 40 | $19,920 | $7,231 | 36.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 47 | 84 | $15,876 | $4,955 | 31.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 34 | 34 | $6,868 | $3,792 | 55.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 48 | 73 | $9,198 | $3,016 | 32.8% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 26 | 33 | $3,689 | $1,711 | 46.4% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 36 | 53 | $3,300 | $1,436 | 43.5% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2020 | 13 | 13 | $4,407 | $957.87 | 21.7% |
About Dr. Odell Smith, MD
Dr. Odell Smith, MD is a Family Medicine healthcare provider based in Crawfordsville, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1609951045.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Odell Smith, MD has received a total of $499.42 in payments from pharmaceutical and medical device companies, with $18.47 received in 2023. These payments were reported across 35 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($499.42).
As a Medicare-enrolled provider, Smith has provided services to 777 Medicare beneficiaries, totaling 1,062 services with total Medicare billing of $86,597. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Crawfordsville, IN
- Active Since 10/26/2006
- Last Updated 03/22/2021
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1609951045
Products in Payments
- TROKENDI XR (Drug) $58.84
- MYRBETRIQ (Drug) $51.65
- LINZESS (Drug) $47.61
- LONHALA MAGNAIR (Drug) $43.77
- Ozempic (Drug) $26.20
- ANORO (Drug) $23.57
- ImmunoCAP (Device) $22.28
- QUDEXY XR Topiramate Extended Release Capsules (Drug) $18.79
- Arctic Sun 5000 (Device) $18.47
- VRAYLAR (Drug) $17.04
- JANUVIA (Drug) $15.93
- Vascepa (Drug) $15.36
- BREO (Drug) $14.95
- TRULICITY (Drug) $14.02
- FARXIGA (Drug) $13.66
- SOLIQUA 100/33 (Biological) $12.15
- LATUDA (Drug) $12.15
- LYRICA (Drug) $11.87
- STIOLTO RESPIMAT (Drug) $11.84
- TOUJEO (Drug) $11.47
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Crawfordsville
Scott Douglas, Md, MD
Family Medicine — Payments: $3,244
Family Medicine $3,244
Dr. Kyle Graper, M.d, M.D
Family Medicine — Payments: $403.17
Family Medicine $403.17
Saira Bano, M.d, M.D
Family Medicine — Payments: $269.81
Family Medicine $269.81
Dr. Charles Friend, D.o, D.O
Family Medicine — Payments: $230.18
Family Medicine $230.18
William Leech, Md, MD
Family Medicine — Payments: $220.65
Family Medicine $220.65
Dr. Wayne Myles, D.o, D.O
Family Medicine — Payments: $193.89
Family Medicine $193.89